{
    "nct_id": "NCT04318028",
    "official_title": "A Pilot Study of 7 Tesla MRI Neuroimaging Biomarkers of Prostate Cancer-Related Cognitive Impairment",
    "inclusion_criteria": "* Ability to understand and the willingness to sign a written informed consent\n* Group 1 (G1): Non-metastatic biopsy-proven prostate cancer patients on current ADT and\n* Group 2 (G2): Demographically (age, cancer stage) matched non-metastatic biopsy proven prostate cancer patients without a history of ADT\n* Ability to undergo imaging procedure without any form of sedation\n* Ability to complete brief cognitive testing on iPad\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of dementia or other neuropsychiatric disease\n* History of other cancer medical therapies other than ADT, narcotics or psychiatric medications\n* Standard contraindications for MRI:\n\n  * Prior work as a machinist or metal worker, or history of metal being removed from the eyes,\n  * Cardiac pacemaker or internal pacing wires,\n  * Non-MRI compatible vena cava filter, vascular aneurysm clip, heart valve, spinal or ventricular shunt, optic implant, neuro-stimulator unit, ocular implant, or intrauterine device, or\n  * Claustrophobia, or uncontrollable motion disorder\n* Currently active second malignancy\n* Any significant cardiovascular conditions (New York Heart Association [NYHA]) class III or IV congestive heart failure, myocardial infarction within 6 months, unstable angina, pacemaker); or\n* Renal disease with calculated creatinine clearance of < 45 ml/min",
    "miscellaneous_criteria": ""
}